Dimension TherapeuticsReview Fortune

Posts tagged Dimension Therapeutics

Analysts Downgrades Report: Dimension Therapeutics Inc (NASDAQ:DMTX)

Steve Dixon, February 1, 2017

Dimension Therapeutics Inc (NASDAQ:DMTX) currently trades at $1.95 which is about -54.12% lower than the 52-week high of $10.47. The trading volume at ready counter …

Greggs announced upbeat sales and profits despite cautions on price increases

Amazon.com, Inc. (NASDAQ:AMZN) set to hire 5,000 new workers in UK as a part of extension

Analyst Summary You Should Be Viewing Today: Thermo Fisher Scientific Inc. (NYSE:TMO), Fidelity National Financial, Inc. (NYSE:FNF)

Alibaba Group Holding Ltd (NYSE:BABA) Expands in Malaysia

Advanced Micro Devices, Inc. (NASDAQ:AMD) Down Due to Ryzen or Pull Back?

Handcuff Hackers: Upgrade Your Security Now

Bitcoin ETF Denied By SEC

PSA group’s annual income surged 92% as it plans to acquire General Motors Company (GM) European segment

Nestle is ready for any kind of opportunity for mergers or acquisitions, claims CEO

Amazon.com, Inc. (NASDAQ:AMZN) set to hire 5,000 new workers in UK as a part of extension

Chesapeake Energy Corporation (NYSE:CHK) finally settles legal fight with Aubrey McClendon’s estate

Important Analyst Assessments of Two Stocks: E. I. du Pont de Nemours and Company (NYSE:DD), Microchip Technology Incorporated (NASDAQ:MCHP)

Posts tagged Dimension Therapeutics

Analysts Downgrades Report: Dimension Therapeutics Inc (NASDAQ:DMTX)